Chemcrux Enterprises Ltd
Incorporated in 1996, Chemcrux Enterprises Ltd manufactures and processes bulk drug intermediates[1]
- Market Cap ₹ 122 Cr.
- Current Price ₹ 82.2
- High / Low ₹ 159 / 64.0
- Stock P/E 29.3
- Book Value ₹ 51.9
- Dividend Yield 1.22 %
- ROCE 6.43 %
- ROE 3.01 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 31.7%
- Company's working capital requirements have reduced from 33.2 days to 16.2 days
Cons
- Company has a low return on equity of 6.46% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 95.27 | 95.15 | 78.47 | 70.01 | 80.65 | 86.08 | |
| 74.56 | 73.69 | 65.10 | 60.78 | 69.50 | 73.88 | |
| Operating Profit | 20.71 | 21.46 | 13.37 | 9.23 | 11.15 | 12.20 |
| OPM % | 21.74% | 22.55% | 17.04% | 13.18% | 13.83% | 14.17% |
| 1.00 | 1.05 | 1.18 | 1.49 | 2.02 | 1.70 | |
| Interest | 0.17 | 0.82 | 0.83 | 1.75 | 3.15 | 2.93 |
| Depreciation | 1.59 | 2.04 | 2.29 | 3.21 | 4.73 | 4.74 |
| Profit before tax | 19.95 | 19.65 | 11.43 | 5.76 | 5.29 | 6.23 |
| Tax % | 25.51% | 26.92% | 26.16% | 32.12% | 29.30% | |
| 14.86 | 14.36 | 8.44 | 3.91 | 3.73 | 4.15 | |
| EPS in Rs | 10.03 | 9.70 | 5.70 | 2.64 | 2.52 | 2.80 |
| Dividend Payout % | 19.93% | 20.63% | 17.55% | 37.88% | 39.71% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -5% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -45% |
| TTM: | 50% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -12% |
| 3 Years: | -37% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 6% |
| Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 |
| Reserves | 39.87 | 51.60 | 57.45 | 59.81 | 62.04 |
| 9.75 | 14.43 | 26.46 | 42.30 | 34.37 | |
| 19.34 | 12.38 | 11.15 | 10.13 | 16.22 | |
| Total Liabilities | 83.77 | 93.22 | 109.87 | 127.05 | 127.44 |
| 25.49 | 33.11 | 33.09 | 77.06 | 74.96 | |
| CWIP | 0.00 | 0.31 | 21.06 | 1.61 | 4.08 |
| Investments | 7.08 | 16.79 | 19.83 | 19.83 | 15.93 |
| 51.20 | 43.01 | 35.89 | 28.55 | 32.47 | |
| Total Assets | 83.77 | 93.22 | 109.87 | 127.05 | 127.44 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 9.16 | 14.82 | 16.34 | 7.59 | 13.85 | |
| -2.64 | -20.48 | -25.89 | -5.98 | -0.07 | |
| 3.96 | 0.96 | 7.64 | -5.66 | -12.36 | |
| Net Cash Flow | 10.49 | -4.70 | -1.91 | -4.04 | 1.42 |
| Free Cash Flow | 4.59 | 3.71 | -6.85 | -0.64 | 8.74 |
| CFO/OP | 69% | 86% | 142% | 98% | 136% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 72.33 | 51.56 | 71.17 | 61.42 | 85.58 |
| Inventory Days | 92.33 | 124.92 | 99.63 | 135.16 | 69.24 |
| Days Payable | 92.57 | 71.19 | 70.84 | 60.56 | 105.39 |
| Cash Conversion Cycle | 72.09 | 105.28 | 99.96 | 136.01 | 49.43 |
| Working Capital Days | 37.43 | 67.28 | 55.49 | 27.94 | 16.16 |
| ROCE % | 27.63% | 13.46% | 6.69% | 6.43% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Domestic Sales Share of Revenue % ・Standalone data |
|
|||||||||||
| Export Sales Share of Revenue % ・Standalone data |
||||||||||||
| Job Work Share of Revenue % ・Standalone data |
||||||||||||
| Permanent Employees count ・Standalone data |
||||||||||||
| Energy Consumption MWh ・Standalone data |
||||||||||||
| Installed Capacity MT/Year ・Standalone data |
||||||||||||
| Total Production Volume MT ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Letter To Shareholders Containing The Web-Link Of The Notice And Annual Report For 30Th AGM
- Chemcrux will hold its 30th AGM on 17 September 2026; annual report and notice web-links shared.
-
Communication For TDS On Dividend For F.Y. 2025-26
- Chemcrux shares TDS details for FY26 final dividend of Re.1, with AGM on 17 Sept 2026 and record date 10 Sept 2026.
-
Announcement under Regulation 30 (LODR)-Cessation
- Bhanubhai Patel and Shailesh Patel ceased as Independent Directors on 23 August 2026 after completing tenure.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication - 30th AGM Notice and other related matters thereto.
- Book Closure Dates And E-Voting Schedule For 30Th AGM
Business Overview:[1][2]
The Company is a manufacturer of chemical intermediates serving the API, dyes and pigments industries. It has capabilities in high-pressure oxidation, nitration, chlorosulfonation and amidation chemistry and operates as a listed MSME, with its operations supported by ISO 9001:2015, ISO 14001:2015 and ISO 50001:2018 certifications, along with an EcoVadis CSR rating.